Microbial Genomics as a Guide to Drug Discovery and Structural Elucidation: ECO-02301, a Novel Antifungal Agent, as an Example
- 12 March 2005
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 68 (4) , 493-496
- https://doi.org/10.1021/np0401664
Abstract
Analysis of the genome of Streptomyces aizunensis NRRL B-11277 indicated its potential to produce a compound of novel and highly predictable structure. The structure was predicted with sufficient accuracy to allow straightforward detection of the specific metabolite in HPLC profiles of fermentation extracts and hence to guide the isolation. The spectroscopic work was reduced to a confirmation of structure rather than a first principle determination. The compound, ECO-02301 (1), demonstrated potent antifungal activity. This work exemplifies not only the discovery of novel antibiotics from well-characterized organisms but also the utility of genomics as a further tool, complementary to spectroscopy, to enable rapid determination of complex structures.Keywords
This publication has 4 references indexed in Scilit:
- A genomics-guided approach for discovering and expressing cryptic metabolic pathwaysNature Biotechnology, 2003
- Genetic Contributions to Understanding Polyketide SynthasesChemical Reviews, 1997
- Modular Peptide Synthetases Involved in Nonribosomal Peptide SynthesisChemical Reviews, 1997
- ORGANIZATION AND EXPRESSION OF GENES INVOLVED IN THE BIOSYNTHESIS OF ANTIBIOTICS AND OTHER SECONDARY METABOLITESAnnual Review of Microbiology, 1989